Healthcare provider profile · identity verified

Scott A. Mclaughlin, MD

Internal Medicine · BANGOR, ME · NPI 1841220431

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	555	174
Amlodipine Besylate	Amlodipine Besylate	447	118
Lisinopril	Lisinopril	320	96
Levothyroxine Sodium	Levothyroxine Sodium	295	82
Pantoprazole Sodium	Pantoprazole Sodium	253	70
Metformin Hcl	Metformin Hcl	239	63
Metoprolol Succinate	Metoprolol Succinate	221	63
Gabapentin	Gabapentin	180	55
Omeprazole	Omeprazole	180	55
Losartan Potassium	Losartan Potassium	179	53
Rosuvastatin Calcium	Rosuvastatin Calcium	173	56
Tamsulosin Hcl	Tamsulosin Hcl	166	49
Metoprolol Tartrate	Metoprolol Tartrate	159	44
Simvastatin	Simvastatin	150	42
Furosemide	Furosemide	148	43
Albuterol Sulfate Hfa	Albuterol Sulfate	144	68
Jardiance	Empagliflozin	138	36
Sertraline Hcl	Sertraline Hcl	133	41
Eliquis	Apixaban	128	33
Prednisone	Prednisone	104	53
Hydrochlorothiazide	Hydrochlorothiazide	98	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	91	15
Allopurinol	Allopurinol	84	26
Oxycodone Hcl	Oxycodone Hcl	83	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	81	20
Carvedilol	Carvedilol	80	22
Trazodone Hcl	Trazodone Hcl	78	29
Lorazepam	Lorazepam	77	19
Warfarin Sodium	Warfarin Sodium	75	20
Potassium Chloride	Potassium Chloride	69	24
Glipizide	Glipizide	68	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	66	17
Escitalopram Oxalate	Escitalopram Oxalate	63	17
Clopidogrel	Clopidogrel Bisulfate	60	20
Duloxetine Hcl	Duloxetine Hcl	59	13
Spironolactone	Spironolactone	59	16
Famotidine	Famotidine	56	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	12
Montelukast Sodium	Montelukast Sodium	48	14
Clonidine Hcl	Clonidine Hcl	47	12
Ozempic	Semaglutide	47	13
Pregabalin	Pregabalin	47	suppressed
Ezetimibe	Ezetimibe	44	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Clonazepam	Clonazepam	43	suppressed
Meloxicam	Meloxicam	42	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	40	30
Metformin Hcl Er	Metformin Hcl	40	13
Tramadol Hcl	Tramadol Hcl	39	13
Amitriptyline Hcl	Amitriptyline Hcl	38	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	16
Mirtazapine	Mirtazapine	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	12
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	36	suppressed
Atenolol	Atenolol	35	12
Xarelto	Rivaroxaban	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	21
Celecoxib	Celecoxib	31	suppressed
Lovastatin	Lovastatin	31	suppressed
Nitroglycerin	Nitroglycerin	31	23
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Glipizide Er	Glipizide	27	suppressed
Oxycontin	Oxycodone Hcl	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Finasteride	Finasteride	26	suppressed
Cephalexin	Cephalexin	25	18
Fluticasone Propionate	Fluticasone Propionate	25	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	18
Baclofen	Baclofen	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Divalproex Sodium	Divalproex Sodium	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Diazepam	Diazepam	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Torsemide	Torsemide	14	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Digoxin	Digoxin	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error